From Twitter, very good for us if they are close to correct.
ATAI Life Sciences (ATAI)In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences, with a price target of $50.00. The company's shares closed last Thursday at $2.80, close to its 52-week low of $2.60.